My Quote Request
6505-01-369-4603
20 Products
PD-2
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694603
NSN
6505-01-369-4603
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER
ADMINISTRATION: WOUND SITE
PRIMARY CONTAINER CONTENT QUANTITY: 2500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: COMES IN A 3000 ML. SIZE CONTAINER; COMPOSITION PER 100 ML.: 2.5 G DEXTROSE; 538 MG. SODIUM CHLORIDE; 448 MG. SODIUM LACTATE; 25.7 MG. CALCIUM CHLORIDE; 5.08 MG. MAGNESIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
NDC00536-4477-01
VALPROIC ACID CAPSULES,USP
NSN, MFG P/N
6505013690513
NSN
6505-01-369-0513
NDC00536-4477-01
VALPROIC ACID CAPSULES,USP
NSN, MFG P/N
6505013690513
NSN
6505-01-369-0513
MFG
RUGBY LABORATORIES INC CONTRACT DEPT
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: GEL FORM
Related Searches:
1879-30
HYDROCOLLOID PASTE
NSN, MFG P/N
6505013691693
NSN
6505-01-369-1693
MFG
CONVATEC BRISTOL MYERS SQUIBB DIV
Description
FEATURES PROVIDED: STERILE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, CONVATEC
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: COMPOSED OF NATURAL HYDROCOLLOIDS; USED FOR DERMAL ULCERATION IN ASSOCIATION W/DUODERM DRESSINGS; HYPOALLERGENIC
Related Searches:
A92K021
HYDROCOLLOID PASTE
NSN, MFG P/N
6505013691693
NSN
6505-01-369-1693
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
FEATURES PROVIDED: STERILE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, CONVATEC
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: COMPOSED OF NATURAL HYDROCOLLOIDS; USED FOR DERMAL ULCERATION IN ASSOCIATION W/DUODERM DRESSINGS; HYPOALLERGENIC
Related Searches:
DUODERM HYDROACTIVE PASTE
HYDROCOLLOID PASTE
NSN, MFG P/N
6505013691693
NSN
6505-01-369-1693
DUODERM HYDROACTIVE PASTE
HYDROCOLLOID PASTE
NSN, MFG P/N
6505013691693
NSN
6505-01-369-1693
MFG
CONVATEC BRISTOL MYERS SQUIBB DIV
Description
FEATURES PROVIDED: STERILE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, CONVATEC
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: COMPOSED OF NATURAL HYDROCOLLOIDS; USED FOR DERMAL ULCERATION IN ASSOCIATION W/DUODERM DRESSINGS; HYPOALLERGENIC
Related Searches:
NDC00003-1879-30
HYDROCOLLOID PASTE
NSN, MFG P/N
6505013691693
NSN
6505-01-369-1693
MFG
CONVATEC BRISTOL MYERS SQUIBB DIV
Description
FEATURES PROVIDED: STERILE
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, CONVATEC
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
SPECIAL FEATURES: COMPOSED OF NATURAL HYDROCOLLOIDS; USED FOR DERMAL ULCERATION IN ASSOCIATION W/DUODERM DRESSINGS; HYPOALLERGENIC
Related Searches:
A93A052
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013692069
NSN
6505-01-369-2069
A93A052
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013692069
NSN
6505-01-369-2069
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE RELEASED PER 24 HOURS
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 120MG/24 HOURS 90S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: UNIT OF USE
Related Searches:
CARDIZEM CD
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013692069
NSN
6505-01-369-2069
CARDIZEM CD
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013692069
NSN
6505-01-369-2069
MFG
SANOFI-AVENTIS U.S. INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE RELEASED PER 24 HOURS
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 120MG/24 HOURS 90S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: UNIT OF USE
Related Searches:
NDC00088-1795-42
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013692069
NSN
6505-01-369-2069
NDC00088-1795-42
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013692069
NSN
6505-01-369-2069
MFG
SANOFI-AVENTIS U.S. INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE RELEASED PER 24 HOURS
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 90.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 120MG/24 HOURS 90S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: UNIT OF USE
Related Searches:
NDC00548-2001-00
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013692846
NSN
6505-01-369-2846
NDC00548-2001-00
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505013692846
NSN
6505-01-369-2846
MFG
INTERNATIONAL MEDICATION SYSTEMS LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DEXTROSE INJECTION USP 50ML SYRINGE NEEDLE UNIT 25S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
CARDIZEM CD
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013693396
NSN
6505-01-369-3396
CARDIZEM CD
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013693396
NSN
6505-01-369-3396
MFG
SANOFI-AVENTIS U.S. INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE RELEASED PER 24 HOURS
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 120MG/24 HOURS 30S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: UNIT OF USE
Related Searches:
F93D029
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013693396
NSN
6505-01-369-3396
F93D029
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013693396
NSN
6505-01-369-3396
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE RELEASED PER 24 HOURS
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 120MG/24 HOURS 30S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: UNIT OF USE
Related Searches:
NDC00088-1795-30
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013693396
NSN
6505-01-369-3396
NDC00088-1795-30
DILTIAZEM EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505013693396
NSN
6505-01-369-3396
MFG
SANOFI-AVENTIS U.S. INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS DILTIAZEM HYDROCHLORIDE RELEASED PER 24 HOURS
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 30.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DILTIAZEM EXTENDED-RELEASE CAPSULES USP 120MG/24 HOURS 30S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
SPECIAL FEATURES: UNIT OF USE
Related Searches:
5B5175
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694602
NSN
6505-01-369-4602
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER
ADMINISTRATION: WOUND SITE
PRIMARY CONTAINER CONTENT QUANTITY: 1500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: COMES IN A 2000 ML. SIZE CONTAINER; COMPOSITION PER 100 ML.: 2.5 G DEXTROSE; 538 MG. SODIUM CHLORIDE; 448 MG. SODIUM LACTATE; 25.7 MG. CALCIUM CHLORIDE; 5.08 MG. MAGNESIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
DIANEL
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694602
NSN
6505-01-369-4602
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER
ADMINISTRATION: WOUND SITE
PRIMARY CONTAINER CONTENT QUANTITY: 1500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: COMES IN A 2000 ML. SIZE CONTAINER; COMPOSITION PER 100 ML.: 2.5 G DEXTROSE; 538 MG. SODIUM CHLORIDE; 448 MG. SODIUM LACTATE; 25.7 MG. CALCIUM CHLORIDE; 5.08 MG. MAGNESIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
NDC00941-0413-45
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694602
NSN
6505-01-369-4602
NDC00941-0413-45
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694602
NSN
6505-01-369-4602
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER
ADMINISTRATION: WOUND SITE
PRIMARY CONTAINER CONTENT QUANTITY: 1500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: COMES IN A 2000 ML. SIZE CONTAINER; COMPOSITION PER 100 ML.: 2.5 G DEXTROSE; 538 MG. SODIUM CHLORIDE; 448 MG. SODIUM LACTATE; 25.7 MG. CALCIUM CHLORIDE; 5.08 MG. MAGNESIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
PD-2
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694602
NSN
6505-01-369-4602
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER
ADMINISTRATION: WOUND SITE
PRIMARY CONTAINER CONTENT QUANTITY: 1500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: COMES IN A 2000 ML. SIZE CONTAINER; COMPOSITION PER 100 ML.: 2.5 G DEXTROSE; 538 MG. SODIUM CHLORIDE; 448 MG. SODIUM LACTATE; 25.7 MG. CALCIUM CHLORIDE; 5.08 MG. MAGNESIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
5B5178
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694603
NSN
6505-01-369-4603
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER
ADMINISTRATION: WOUND SITE
PRIMARY CONTAINER CONTENT QUANTITY: 2500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: COMES IN A 3000 ML. SIZE CONTAINER; COMPOSITION PER 100 ML.: 2.5 G DEXTROSE; 538 MG. SODIUM CHLORIDE; 448 MG. SODIUM LACTATE; 25.7 MG. CALCIUM CHLORIDE; 5.08 MG. MAGNESIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
DIANEL
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694603
NSN
6505-01-369-4603
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER
ADMINISTRATION: WOUND SITE
PRIMARY CONTAINER CONTENT QUANTITY: 2500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: COMES IN A 3000 ML. SIZE CONTAINER; COMPOSITION PER 100 ML.: 2.5 G DEXTROSE; 538 MG. SODIUM CHLORIDE; 448 MG. SODIUM LACTATE; 25.7 MG. CALCIUM CHLORIDE; 5.08 MG. MAGNESIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER
Related Searches:
NDC00941-0413-48
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694603
NSN
6505-01-369-4603
NDC00941-0413-48
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013694603
NSN
6505-01-369-4603
MFG
BAXTER HEALTHCARE CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER
ADMINISTRATION: WOUND SITE
PRIMARY CONTAINER CONTENT QUANTITY: 2500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: COMES IN A 3000 ML. SIZE CONTAINER; COMPOSITION PER 100 ML.: 2.5 G DEXTROSE; 538 MG. SODIUM CHLORIDE; 448 MG. SODIUM LACTATE; 25.7 MG. CALCIUM CHLORIDE; 5.08 MG. MAGNESIUM CHLORIDE
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER